Beissert S - Search Results

1

Cutaneous autoimmune diseases during COVID-19 pandemic.

Günther C, Aschoff R, Beissert S. Günther C, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e667-e670. doi: 10.1111/jdv.16753. Epub 2020 Jul 2. J Eur Acad Dermatol Venereol. 2020. PMID: 32534461 Free PMC article. No abstract available.

2

Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.

Hüsken AC, Tsianakas A, Hensen P, Nashan D, Loquai C, Beissert S, Luger TA, Sunderkötter C, Schiller M. Hüsken AC, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2012 Jan;26(1):71-8. doi: 10.1111/j.1468-3083.2011.04011.x. Epub 2011 Mar 9. J Eur Acad Dermatol Venereol. 2012. PMID: 22168776

3

[Lupus erythematosus].

Günther C, Beissert S. Günther C, et al. Among authors: beissert s. Hautarzt. 2015 Aug;66(8):611-6. doi: 10.1007/s00105-015-3644-7. Hautarzt. 2015. PMID: 26025373 Review. German.

4

[Autoimmune skin diseases].

Beissert S, Hertl M. Beissert S, et al. Hautarzt. 2015 Aug;66(8):572-3. doi: 10.1007/s00105-015-3666-1. Hautarzt. 2015. PMID: 26228173 German. No abstract available.

5

A chronic recurrent disease course of dermatomyositis is associated with autoantibodies against transcriptional intermediary factor 1-γ.

Meisterfeld S, Röber N, Conrad K, Beissert S, Aringer M, Günther C. Meisterfeld S, et al. Among authors: beissert s. Br J Dermatol. 2017 Aug;177(2):590-593. doi: 10.1111/bjd.15468. Epub 2017 Jul 5. Br J Dermatol. 2017. PMID: 28314058 No abstract available.

6

Toll-Like Receptor-Mediated Upregulation of CXCL16 in Psoriasis Orchestrates Neutrophil Activation.

Steffen S, Abraham S, Herbig M, Schmidt F, Blau K, Meisterfeld S, Beissert S, Guck J, Günther C. Steffen S, et al. Among authors: beissert s. J Invest Dermatol. 2018 Feb;138(2):344-354. doi: 10.1016/j.jid.2017.08.041. Epub 2017 Sep 20. J Invest Dermatol. 2018. PMID: 28942364 Free article.

7

Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgaris.

Dietze J, Hohenstein B, Tselmin S, Julius U, Bornstein SR, Beissert S, Günther C. Dietze J, et al. Among authors: beissert s. Atheroscler Suppl. 2017 Nov;30:271-277. doi: 10.1016/j.atherosclerosissup.2017.05.044. Epub 2017 Jun 3. Atheroscler Suppl. 2017. PMID: 29096849

8

Linear Hyperkeratotic Papules on Extremities Together with Oral Ulcers: A Quiz.

Heyne S, Hägele B, Beissert S, Günther C. Heyne S, et al. Among authors: beissert s. Acta Derm Venereol. 2019 Sep 1;99(10):939-940. doi: 10.2340/00015555-3239. Acta Derm Venereol. 2019. PMID: 31197385 Free article. No abstract available.

9

Medical treatment of advanced cutaneous squamous-cell carcinoma.

Gellrich FF, Hüning S, Beissert S, Eigentler T, Stockfleth E, Gutzmer R, Meier F. Gellrich FF, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:38-43. doi: 10.1111/jdv.16024. J Eur Acad Dermatol Venereol. 2019. PMID: 31833610 Review.

10

Human Papilloma Virus-positive Squamous Cell Carcinoma of the Oropharynx Arising in Pemphigus Vulgaris.

Lehr S, Heyne S, Berndt K, Beissert S, Abraham S, Günther C. Lehr S, et al. Among authors: beissert s. Acta Derm Venereol. 2020 May 11;100(10):adv00132. doi: 10.2340/00015555-3478. Acta Derm Venereol. 2020. PMID: 32250440 Free PMC article. No abstract available.

11

COVID-19 and implications for dermatological and allergological diseases.

Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. Buhl T, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Aug;18(8):815-824. doi: 10.1111/ddg.14195. Epub 2020 Jul 27. J Dtsch Dermatol Ges. 2020. PMID: 32717116 Review.

12

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

Joly P, Horvath B, Patsatsi Α, Uzun S, Bech R, Beissert S, Bergman R, Bernard P, Borradori L, Caproni M, Caux F, Cianchini G, Daneshpazhooh M, De D, Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R, Guenther C, Hofmann S, Ioannides D, Kowalewski C, Ludwig R, Lim YL, Marinovic B, Marzano AV, Mascaró JM Jr, Mimouni D, Murrell DF, Pincelli C, Squarcioni CP, Sárdy M, Setterfield J, Sprecher E, Vassileva S, Wozniak K, Yayli S, Zambruno G, Zillikens D, Hertl M, Schmidt E. Joly P, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1900-1913. doi: 10.1111/jdv.16752. Epub 2020 Aug 24. J Eur Acad Dermatol Venereol. 2020. PMID: 32830877 Free article.

13

Osteo-odonto-keratoprosthesis restores vision in ocular mucous membrane pemphigoid.

Kochan AS, Hille K, Zahnert B, Heyne S, Beissert S, Günther C. Kochan AS, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2021 Jan;19(1):129-132. doi: 10.1111/ddg.14259. Epub 2020 Sep 10. J Dtsch Dermatol Ges. 2021. PMID: 32909368 No abstract available.

14

Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic.

Aschoff R, Zimmermann N, Beissert S, Günther C. Aschoff R, et al. Among authors: beissert s. Dermatopathology (Basel). 2020 Dec 4;7(3):57-63. doi: 10.3390/dermatopathology7030010. Dermatopathology (Basel). 2020. PMID: 33291622 Free PMC article.

15

Wiederherstellung der Sehkraft durch Osteo-Odonto-Keratoprothese nach Erblindung bei okulärem Schleimhautpemphigoid.

Kochan AS, Hille K, Zahnert B, Heyne S, Beissert S, Günther C. Kochan AS, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2021 Jan;19(1):129-132. doi: 10.1111/ddg.14259_g. J Dtsch Dermatol Ges. 2021. PMID: 33491896 German. No abstract available.

16

COVID-19 and immune checkpoint inhibitors.

Ahmed MS, Brehme H, Friedrich S, Reinhardt L, Blum S, Beissert S, Meier F. Ahmed MS, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2021 May;35(5):e312-e314. doi: 10.1111/jdv.17172. Epub 2021 Feb 25. J Eur Acad Dermatol Venereol. 2021. PMID: 33587787 Free PMC article. No abstract available.

17

Treatment-resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors.

Povilaityte E, Gellrich FF, Beissert S, Abraham S, Meier F, Günther C. Povilaityte E, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e591-e593. doi: 10.1111/jdv.17321. Epub 2021 May 13. J Eur Acad Dermatol Venereol. 2021. PMID: 33914970 No abstract available.

18

[Terbinafine-resistant dermatophytoses and onychomycosis due to Trichophyton rubrum].

Appelt L, Nenoff P, Uhrlaß S, Krüger C, Kühn P, Eichhorn K, Buder S, Beissert S, Abraham S, Aschoff R, Bauer A. Appelt L, et al. Among authors: beissert s. Hautarzt. 2021 Oct;72(10):868-877. doi: 10.1007/s00105-021-04879-1. Epub 2021 Aug 30. Hautarzt. 2021. PMID: 34459941 Review. German.

19

Annular erythematous plaques as manifestation of vasculitis in pediatric Sjögren's syndrome.

Appelt LM, Lander F, Beissert S, Günther C. Appelt LM, et al. Among authors: beissert s. Rheumatology (Oxford). 2022 Feb 2;61(2):e43-e45. doi: 10.1093/rheumatology/keab736. Rheumatology (Oxford). 2022. PMID: 34599800 No abstract available.

20

Documentation of psoriasis in routine care - expert consensus on a German data set.

Otten M, Mrowietz U, von Kiedrowski RM, Otto R, Altenburg A, Aschoff R, Beissert S, Beiteke U, Bonnekoh B, Hoffmann M, Körber A, Maaßen D, Mössner R, Navarini A, Petering H, Ramaker-Brunke J, Rosenbach T, Schwichtenberg U, Sticherling M, Sondermann W, Thaci D, Timmel A, Tsianakas A, Werfel T, Wilsmann-Theis D, Augustin M. Otten M, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2021 Oct;19(10):1463-1475. doi: 10.1111/ddg.14547. Epub 2021 Oct 7. J Dtsch Dermatol Ges. 2021. PMID: 34622544

21

Molecular mechanisms of vasculopathy and coagulopathy in COVID-19.

Al-Gburi S, Beissert S, Günther C. Al-Gburi S, et al. Among authors: beissert s. Biol Chem. 2021 Oct 19;402(12):1505-1518. doi: 10.1515/hsz-2021-0245. Print 2021 Nov 25. Biol Chem. 2021. PMID: 34657406 Review.

22

Dokumentation der Psoriasis in der Routineversorgung - Expertenkonsens zu einem deutschen Datensatz.

Otten M, Mrowietz U, von Kiedrowski RM, Otto R, Altenburg A, Aschoff R, Beissert S, Beiteke U, Bonnekoh B, Hoffmann M, Körber A, Maaßen D, Mössner R, Navarini A, Petering H, Ramaker-Brunke J, Rosenbach T, Schwichtenberg U, Sticherling M, Sondermann W, Thaci D, Timmel A, Tsianakas A, Werfel T, Wilsmann-Theis D, Augustin M. Otten M, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2021 Oct;19(10):1463-1477. doi: 10.1111/ddg.14547_g. J Dtsch Dermatol Ges. 2021. PMID: 34661349 German.

23

Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib.

Fischer K, Aringer M, Steininger J, Heil J, Beissert S, Abraham S, Günther C. Fischer K, et al. Among authors: beissert s. Br J Dermatol. 2022 Sep;187(3):432-435. doi: 10.1111/bjd.21252. Epub 2022 May 20. Br J Dermatol. 2022. PMID: 35318646 No abstract available.

24

Examination of Subungual Hematomas and Subungual Melanocytic Lesions by Using Optical Coherence Tomography and Dermoscopy.

Hobelsberger S, Laske J, Aschoff R, Beissert S. Hobelsberger S, et al. Among authors: beissert s. Dermatology. 2022;238(6):1130-1138. doi: 10.1159/000524347. Epub 2022 May 4. Dermatology. 2022. PMID: 35508112 Free article.

25

Operative Treatment of Severe Allergic Reactions to Red Tattoo Dye: Presentation and Comparison of Possible Surgical Procedures in Seven Patients.

Laske J, Maschke J, Bauer A, Beissert S, Aschoff R. Laske J, et al. Among authors: beissert s. J Cutan Aesthet Surg. 2022 Jan-Mar;15(1):24-32. doi: 10.4103/JCAS.JCAS_202_20. J Cutan Aesthet Surg. 2022. PMID: 35655643 Free PMC article.

26

Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells.

Schielke L, Zimmermann N, Hobelsberger S, Steininger J, Strunk A, Blau K, Hernandez J, Künzel S, Ziegenbalg R, Rösing S, Beissert S, Abraham S, Günther C. Schielke L, et al. Among authors: beissert s. Front Immunol. 2022 Jun 17;13:916701. doi: 10.3389/fimmu.2022.916701. eCollection 2022. Front Immunol. 2022. PMID: 35784287 Free PMC article.

27

A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients.

Eugster A, Müller D, Gompf A, Reinhardt S, Lindner A, Ashton M, Zimmermann N, Beissert S, Bonifacio E, Günther C. Eugster A, et al. Among authors: beissert s. Front Immunol. 2022 Jul 13;13:897500. doi: 10.3389/fimmu.2022.897500. eCollection 2022. Front Immunol. 2022. PMID: 35911727 Free PMC article.

28

Course and outcome of chilblain-like acral lesions during COVID-19 pandemic.

Blau K, Lehr S, Aschoff R, Al Gburi S, Brück N, Chapsa M, Schnabel A, Abraham S, Jöhrens K, Beissert S, Günther C. Blau K, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e29-e31. doi: 10.1111/jdv.18582. Epub 2022 Oct 1. J Eur Acad Dermatol Venereol. 2023. PMID: 36149533 Free PMC article. No abstract available.

29

Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients.

Eugster A, Müller D, Gompf A, Reinhardt S, Lindner A, Ashton M, Zimmermann N, Beissert S, Bonifacio E, Günther C. Eugster A, et al. Among authors: beissert s. Front Immunol. 2022 Nov 25;13:1094578. doi: 10.3389/fimmu.2022.1094578. eCollection 2022. Front Immunol. 2022. PMID: 36518762 Free PMC article.

30

Psoriasis vulgaris treated successfully with mycophenolate mofetil.

Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA. Haufs MG, et al. Among authors: beissert s. Br J Dermatol. 1998 Jan;138(1):179-81. doi: 10.1046/j.1365-2133.1998.02048.x. Br J Dermatol. 1998. PMID: 9536244

31

Treatment of severe lichen planus with mycophenolate mofetil.

Frieling U, Bonsmann G, Schwarz T, Luger TA, Beissert S. Frieling U, et al. Among authors: beissert s. J Am Acad Dermatol. 2003 Dec;49(6):1063-6. doi: 10.1016/s0190-9622(03)02111-x. J Am Acad Dermatol. 2003. PMID: 14639385

32

Mechanisms of immune-mediated skin diseases: an overview.

Beissert S, Cavazzana I, Mascia F, Meroni P, Pastore S, Tessari G, Girolomoni G. Beissert S, et al. Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S1-6. Clin Exp Rheumatol. 2006. PMID: 16466619 Review.

33

Therapeutic modulation of cutaneous autoimmunity by regulatory T cells.

Loser K, Beissert S. Loser K, et al. Among authors: beissert s. Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii20-2. doi: 10.1093/rheumatology/kel286. Rheumatology (Oxford). 2006. PMID: 16987825 Review.

34

Azathioprine in the treatment of autoimmune blistering diseases.

Meyer V, Beissert S. Meyer V, et al. Among authors: beissert s. Dermatol Clin. 2011 Oct;29(4):545-54. doi: 10.1016/j.det.2011.06.009. Dermatol Clin. 2011. PMID: 21924996

35

Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid.

Schulz S, Deuster D, Schmidt E, Bonsmann G, Beissert S. Schulz S, et al. Among authors: beissert s. Int J Dermatol. 2011 Sep;50(9):1129-31. doi: 10.1111/j.1365-4632.2010.04707.x. Int J Dermatol. 2011. PMID: 22126878 No abstract available.

36

Azathioprine in the treatment of autoimmune blistering diseases.

Meyer V, Beissert S. Meyer V, et al. Among authors: beissert s. Immunol Allergy Clin North Am. 2012 May;32(2):295-307, vii-viii. doi: 10.1016/j.iac.2012.04.009. Immunol Allergy Clin North Am. 2012. PMID: 22560142

37

Knowledge of outdoor workers on the effects of natural UV radiation and methods of protection against exposure.

Hault K, Rönsch H, Beissert S, Knuschke P, Bauer A. Hault K, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2016 Apr;30 Suppl 3:34-7. doi: 10.1111/jdv.13631. J Eur Acad Dermatol Venereol. 2016. PMID: 26995021 Review.

38

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany.

Heratizadeh A, Haufe E, Stölzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach-Renz P, Asmussen A, Schwarz B, Bell M, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Biedermann T, Weidinger S, Schmitt J, Werfel T; TREATgermany Study Group. Heratizadeh A, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1263-1272. doi: 10.1111/jdv.16078. Epub 2020 Feb 13. J Eur Acad Dermatol Venereol. 2020. PMID: 31721316

39

Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards?

Grabbe S, Beissert S, Enk A. Grabbe S, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Aug;18(8):810-813. doi: 10.1111/ddg.14194. Epub 2020 Aug 2. J Dtsch Dermatol Ges. 2020. PMID: 32743938 Free PMC article. Review.

40

A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE).

Pinter A, Hoffmann M, Reich K, Augustin M, Kaplan K, Gudjónsdóttir SD, Delvin T, Mrowietz U; CHANGE investigator group. Pinter A, et al. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):701-711. doi: 10.1111/jdv.16932. Epub 2020 Dec 23. J Eur Acad Dermatol Venereol. 2021. PMID: 32939860 Clinical Trial.

41

Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.

Sadik CD, Rashid H, Hammers CM, Diercks GFH, Weidinger A, Beissert S, Schauer F, Fettiplace J, Thaçi D, Ngai Y, Nunn MA, Zillikens D, Horváth B. Sadik CD, et al. Among authors: beissert s. JAMA Dermatol. 2022 Jun 1;158(6):641-649. doi: 10.1001/jamadermatol.2022.1156. JAMA Dermatol. 2022. PMID: 35507334 Free PMC article. Clinical Trial.

42

Successful treatment of disseminated verrucae vulgares with interferon-beta.

Beissert S, Koch U, Sunderkötter C, Luger TA, Schwarz T. Beissert S, et al. J Am Acad Dermatol. 1993 Dec;29(6):1041-2. doi: 10.1016/s0190-9622(08)82042-7. J Am Acad Dermatol. 1993. PMID: 8245242 No abstract available.

43

Dendritic cells under investigation in autoimmune disease.

Mehling A, Beissert S. Mehling A, et al. Among authors: beissert s. Crit Rev Biochem Mol Biol. 2003;38(1):1-21. doi: 10.1080/713609208. Crit Rev Biochem Mol Biol. 2003. PMID: 12641341 Review.

44

Regulatory T cells.

Beissert S, Schwarz A, Schwarz T. Beissert S, et al. J Invest Dermatol. 2006 Jan;126(1):15-24. doi: 10.1038/sj.jid.5700004. J Invest Dermatol. 2006. PMID: 16417213 Free article. Review.

45

Sun exposure: perceptions and behaviours in outdoor workers.

Bauer A, Rönsch H, Hault K, Püschel A, Knuschke P, Beissert S. Bauer A, et al. Among authors: beissert s. Br J Dermatol. 2014 Dec;171(6):1570-2. doi: 10.1111/bjd.13149. Epub 2014 Nov 2. Br J Dermatol. 2014. PMID: 24891217 No abstract available.

46

Human papillomavirus is a risk factor for asymptomatic bacterial sexually transmitted infections in HIV-infected men who have sex with men.

Spornraft-Ragaller P, Beissert S. Spornraft-Ragaller P, et al. Among authors: beissert s. Br J Dermatol. 2016 Apr;174(4):717-8. doi: 10.1111/bjd.14432. Br J Dermatol. 2016. PMID: 27115585 No abstract available.

47

Tattoo-associated complications of metastatic melanoma treated with dabrafenib and trametinib.

Laske J, Meier F, Bauer A, Beissert S, Garzarolli M. Laske J, et al. Among authors: beissert s. Melanoma Res. 2018 Oct;28(5):485-487. doi: 10.1097/CMR.0000000000000486. Melanoma Res. 2018. PMID: 30148769 No abstract available.

48

Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany.

Abraham S, Haufe E, Harder I, Heratizadeh A, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, Biedermann T, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach P, Asmussen A, Schwarz B, Bell M, Neubert K, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Werfel T, Weidinger S, Schmitt J; TREATgermany study group. Abraham S, et al. Among authors: beissert s. Br J Dermatol. 2020 Aug;183(2):382-384. doi: 10.1111/bjd.18958. Epub 2020 Apr 13. Br J Dermatol. 2020. PMID: 32068242 No abstract available.

49

Cytokines of the IL-17 family in psoriasis.

Lauffer F, Eyerich K, Boehncke WH, Asadullah K, Beissert S, Ghoreschi K, Schön MP. Lauffer F, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Jul;18(7):675-681. doi: 10.1111/ddg.14124. Epub 2020 May 24. J Dtsch Dermatol Ges. 2020. PMID: 32447845 Review.

50

Occupational allergy to phytase: case series of eight production workers exposed to animal feed additives.

Kuske M, Berndt K, Spornraft-Ragaller P, Neumeister V, Raulf M, Sander I, Koschel D, Bickhardt J, Beissert S, Bauer A. Kuske M, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Aug;18(8):859-865. doi: 10.1111/ddg.14205. Epub 2020 Aug 7. J Dtsch Dermatol Ges. 2020. PMID: 32767463

51

Low Threshold for Cutaneous Allergen Sensitization but No Spontaneous Dermatitis or Atopy in FLG-Deficient Mice.

Muhandes L, Chapsa M, Pippel M, Behrendt R, Ge Y, Dahl A, Yi B, Dalpke A, Winkler S, Hiller M, Boutin S, Beissert S, Jessberger R, Fallon PG, Roers A. Muhandes L, et al. Among authors: beissert s. J Invest Dermatol. 2021 Nov;141(11):2611-2619.e2. doi: 10.1016/j.jid.2021.02.763. Epub 2021 Apr 22. J Invest Dermatol. 2021. PMID: 33894197 Free article.

52

Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.

Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Papp KA, et al. Among authors: beissert s. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21. Br J Dermatol. 2021. PMID: 34157132 Free PMC article. Clinical Trial.

53

High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.

Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F. Westphal D, et al. Among authors: beissert s. Br J Dermatol. 2021 Dec;185(6):1186-1199. doi: 10.1111/bjd.20604. Epub 2021 Aug 18. Br J Dermatol. 2021. PMID: 34185311

54

Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.

Metze D, Reimann S, Beissert S, Luger T. Metze D, et al. Among authors: beissert s. J Am Acad Dermatol. 1999 Oct;41(4):533-9. J Am Acad Dermatol. 1999. PMID: 10495371 Clinical Trial.

55

UVA rush hardening for the treatment of solar urticaria.

Beissert S, Ständer H, Schwarz T. Beissert S, et al. J Am Acad Dermatol. 2000 Jun;42(6):1030-2. doi: 10.1016/s0190-9622(00)90299-8. J Am Acad Dermatol. 2000. PMID: 10827409

56

FK506 controls CD40L-induced systemic autoimmunity in mice.

Loser K, Balkow S, Higuchi T, Apelt J, Kuhn A, Luger TA, Beissert S. Loser K, et al. Among authors: beissert s. J Invest Dermatol. 2006 Jun;126(6):1307-15. doi: 10.1038/sj.jid.5700185. J Invest Dermatol. 2006. PMID: 16470176 Free article.

57

A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.

Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA. Beissert S, et al. Arch Dermatol. 2006 Nov;142(11):1447-54. doi: 10.1001/archderm.142.11.1447. Arch Dermatol. 2006. PMID: 17116835 Clinical Trial.

58

Dendritic cells and T cells in the regulation of cutaneous immunity.

Loser K, Beissert S. Loser K, et al. Among authors: beissert s. Adv Dermatol. 2007;23:307-33. doi: 10.1016/j.yadr.2007.07.014. Adv Dermatol. 2007. PMID: 18159907 Review.

59

Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.

Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, Anhalt GJ. Beissert S, et al. J Invest Dermatol. 2010 Aug;130(8):2041-8. doi: 10.1038/jid.2010.91. Epub 2010 Apr 22. J Invest Dermatol. 2010. PMID: 20410913 Free article. Clinical Trial.

60

[Prevention of occupational solar UV radiation-induced epithelial skin cancer].

Bauer A, Beissert S, Knuschke P. Bauer A, et al. Among authors: beissert s. Hautarzt. 2015 Mar;66(3):173-8. doi: 10.1007/s00105-015-3584-2. Hautarzt. 2015. PMID: 25687945 German.

61

Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.

Klenner L, Hafezi W, Clausen BE, Lorentzen EU, Luger TA, Beissert S, Kühn JE, Loser K. Klenner L, et al. Among authors: beissert s. J Invest Dermatol. 2015 Nov;135(11):2676-2687. doi: 10.1038/jid.2015.225. Epub 2015 Jun 15. J Invest Dermatol. 2015. PMID: 26076314 Free article.

62

Systemic therapy of metastatic melanoma.

Rauschenberg R, Garzarolli M, Dietrich U, Beissert S, Meier F. Rauschenberg R, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2015 Dec;13(12):1223-35; quiz 1236-7. doi: 10.1111/ddg.12891. J Dtsch Dermatol Ges. 2015. PMID: 26612791 Review.

63

Congenital dermatofibrosarcoma protuberans clinically mimicking a melanocytic naevus treated with serial excisions.

Laske J, Sergon M, Mentzel T, Beissert S, Maschke J. Laske J, et al. Among authors: beissert s. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e541-e542. doi: 10.1111/jdv.14412. Epub 2017 Jul 12. J Eur Acad Dermatol Venereol. 2017. PMID: 28622423 No abstract available.

64

Non-IgE-dependent hypersensitivity to macrogol 6000.

Berndt K, Kuske M, Beissert S, Spornraft-Ragaller P, Bauer A. Berndt K, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2018 Apr;16(4):479-481. doi: 10.1111/ddg.13479. Epub 2018 Mar 26. J Dtsch Dermatol Ges. 2018. PMID: 29578283 No abstract available.

65

Epidermolytic ichthyosis due to a de novo missense mutation c.1307T> C; p.Leu436Pro in KRT10.

Kuske M, Berndt K, Meinel G, Abraham S, Oji V, Reicherter K, Hörtnagel K, Beissert S, Bauer A. Kuske M, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2019 Jan;17(1):82-84. doi: 10.1111/ddg.13720. Epub 2018 Dec 6. J Dtsch Dermatol Ges. 2019. PMID: 30520551 No abstract available.

66

Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey.

Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, Lain E, Layton A, Rocha M, Weiss J, Dréno B. Tan J, et al. Among authors: beissert s. Am J Clin Dermatol. 2022 Jan;23(1):115-123. doi: 10.1007/s40257-021-00628-1. Epub 2021 Oct 27. Am J Clin Dermatol. 2022. PMID: 34705166 Free PMC article.

67

Psoriasis-Therapie während Schwangerschaft und Stillzeit.

Balakirski G, Gerdes S, Beissert S, Ochsendorf F, von Kiedrowski R, Wilsmann-Theis D. Balakirski G, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2022 May;20(5):653-685. doi: 10.1111/ddg.14789_g. J Dtsch Dermatol Ges. 2022. PMID: 35578434

68

Therapy of psoriasis during pregnancy and breast-feeding.

Balakirski G, Gerdes S, Beissert S, Ochsendorf F, von Kiedrowski R, Wilsmann-Theis D. Balakirski G, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2022 May;20(5):653-683. doi: 10.1111/ddg.14789. J Dtsch Dermatol Ges. 2022. PMID: 35578438 Review.

69

Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial.

Blauvelt A, Langley RG, Lacour JP, Toth D, Laquer V, Beissert S, Wollenberg A, Herranz P, Pink AE, Peris K, Fangel S, Gjerum L, Corriveau J, Saeki H, Warren RB, Simpson E, Reich K. Blauvelt A, et al. Among authors: beissert s. J Am Acad Dermatol. 2022 Oct;87(4):815-824. doi: 10.1016/j.jaad.2022.07.019. Epub 2022 Jul 19. J Am Acad Dermatol. 2022. PMID: 35863467 Free article.

70

Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study.

Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, Lain E, Layton A, Rocha M, Weiss J, Dréno B. Tan J, et al. Among authors: beissert s. Dermatol Ther (Heidelb). 2022 Aug;12(8):1847-1858. doi: 10.1007/s13555-022-00768-0. Epub 2022 Jul 29. Dermatol Ther (Heidelb). 2022. PMID: 35904707 Free PMC article.

71

UV-induced cutaneous photobiology.

Beissert S, Granstein RD. Beissert S, et al. Crit Rev Biochem Mol Biol. 1996 Dec;31(5-6):381-404. doi: 10.3109/10409239609108723. Crit Rev Biochem Mol Biol. 1996. PMID: 8994803 Review.

72

Occupational immediate-type allergy to locusts in a zookeeper.

Rauschenberg R, Bauer A, Beissert S, Spornraft-Ragaller P. Rauschenberg R, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2015 Feb;13(2):157-8. doi: 10.1111/ddg.12442. J Dtsch Dermatol Ges. 2015. PMID: 25631136 English, German. No abstract available.

73

[Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies].

Riemekasten G, Beissert S, Distler JH, Kreuter A, Müller-Ladner U. Riemekasten G, et al. Among authors: beissert s. Z Rheumatol. 2017 Apr;76(3):228-237. doi: 10.1007/s00393-016-0177-0. Z Rheumatol. 2017. PMID: 27535277 German.

74

Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.

Kuske M, Rauschenberg R, Garzarolli M, Meredyth-Stewart M, Beissert S, Troost EGC, Glitza OIC, Meier F. Kuske M, et al. Among authors: beissert s. Am J Clin Dermatol. 2018 Aug;19(4):529-541. doi: 10.1007/s40257-018-0346-9. Am J Clin Dermatol. 2018. PMID: 29417399 Free PMC article. Review.

75

Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy.

Kuske M, Westphal D, Wehner R, Schmitz M, Beissert S, Praetorius C, Meier F. Kuske M, et al. Among authors: beissert s. Pharmacol Res. 2018 Oct;136:151-159. doi: 10.1016/j.phrs.2018.08.019. Epub 2018 Aug 23. Pharmacol Res. 2018. PMID: 30145328 Free article. Review.

76

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.

Rauschenberg R, Bruns J, Brütting J, Daubner D, Lohaus F, Zimmer L, Forschner A, Zips D, Hassel JC, Berking C, Kaehler KC, Utikal J, Gutzmer R, Terheyden P, Meiss F, Rafei-Shamsabadi D, Kiecker F, Debus D, Dabrowski E, Arnold A, Garzarolli M, Kuske M, Beissert S, Löck S, Linn J, Troost EGC, Meier F. Rauschenberg R, et al. Among authors: beissert s. Eur J Cancer. 2019 Mar;110:11-20. doi: 10.1016/j.ejca.2018.12.023. Epub 2019 Feb 7. Eur J Cancer. 2019. PMID: 30739835 Free article.

77

Characteristics and coinfection with syphilis in newly HIV-infected patients at the University Hospital Dresden 1987-2012.

Spornraft-Ragaller P, Schmitt J, Stephan V, Boashie U, Beissert S. Spornraft-Ragaller P, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2014 Aug;12(8):707-16. doi: 10.1111/ddg.12382. Epub 2014 Jun 18. J Dtsch Dermatol Ges. 2014. PMID: 24941863

78

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP. Murrell DF, et al. Among authors: beissert s. J Am Acad Dermatol. 2015 Jan;72(1):168-74. doi: 10.1016/j.jaad.2014.08.024. Epub 2014 Nov 4. J Am Acad Dermatol. 2015. PMID: 25443626 Free article. Review.

79

Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.

Rossiter H, Beissert S, Mayer C, Schön MP, Wienrich BG, Tschachler E, Kupper TS. Rossiter H, et al. Among authors: beissert s. Cancer Res. 2001 May 1;61(9):3619-26. Cancer Res. 2001. PMID: 11325830

80

Phototherapy: a promising treatment option for skin sclerosis in scleroderma?

Sunderkötter C, Kuhn A, Hunzelmann N, Beissert S. Sunderkötter C, et al. Among authors: beissert s. Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii52-iii54. doi: 10.1093/rheumatology/kel293. Rheumatology (Oxford). 2006. PMID: 16987838 Review.

81

Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes?

Schröder JM, Reich K, Kabashima K, Liu FT, Romani N, Metz M, Kerstan A, Lee PH, Loser K, Schön MP, Maurer M, Stoitzner P, Beissert S, Tokura Y, Gallo RL. Schröder JM, et al. Among authors: beissert s. Exp Dermatol. 2006 Nov;15(11):913-29. doi: 10.1111/j.1600-0625.2006.00506_1.x. Exp Dermatol. 2006. PMID: 17002689 Free article. Review.

82

LFA-1 contributes to signal I of T-cell activation and to the production of T(h)1 cytokines.

Varga G, Nippe N, Balkow S, Peters T, Wild MK, Seeliger S, Beissert S, Krummen M, Roth J, Sunderkötter C, Grabbe S. Varga G, et al. Among authors: beissert s. J Invest Dermatol. 2010 Apr;130(4):1005-12. doi: 10.1038/jid.2009.398. Epub 2010 Jan 14. J Invest Dermatol. 2010. PMID: 20072134 Free article.

83

Regulatory T cells: banned cells for decades.

Loser K, Beissert S. Loser K, et al. Among authors: beissert s. J Invest Dermatol. 2012 Mar;132(3 Pt 2):864-71. doi: 10.1038/jid.2011.375. Epub 2011 Dec 8. J Invest Dermatol. 2012. PMID: 22158548 Free article. Review.

84

Acceptance and usability of different sunscreen formulations among outdoor workers: a randomized, single-blind, cross-over study.

Bauer A, Hault K, Püschel A, Rönsch H, Knuschke P, Beissert S. Bauer A, et al. Among authors: beissert s. Acta Derm Venereol. 2014 Mar;94(2):152-6. doi: 10.2340/00015555-1667. Acta Derm Venereol. 2014. PMID: 23995520 Free article. Clinical Trial.

85

[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology].

Reich-Schupke S, Alm J, Altmeyer P, Bachter D, Bayerl C, Beissert S, Bieber T, Böhmer J, Dill D, Dippel E, Dücker P, Effendy I, El Gammal S, Elsner P, Enk A, Feldmann-Böddeker I, Frank H, Gehring W, Gieler U, Goebeler M, Görge T, Gollnick H, Grabbe S, Gross G, Gudat W, Happ A, Herbst R, Hermes B, Hoff NP, John SM, Jungelhülsing M, Jünger M, Kaatz M, Kapp A, Kaufmann R, Klode J, Knaber K, König A, Krieg T, Kohl P, Kowalzick L, Lehmann P, Löffler H, Maschke J, Marsch W, Mechtel D, Mohr P, Moll I, Müller M, Nashan D, Ockenfels HM, Peter RU, Pillekamp H, Rompel R, Ruzicka T, Salfeld K, Sander C, Schaller J, Scharffetter-Kochanek K, Schuler G, Schulze HJ, Schwarz T, Splieth B, Stege H, Stolz W, Strölin A, Tran H, Tronnier M, Ulrich J, Vogt T, Wagner G, Welzel J, Willgeroth T, Wollina U, Zillikens D, Zouboulis CC, Zuberbier T, Zutt M, Stücker M. Reich-Schupke S, et al. Among authors: beissert s. Hautarzt. 2013 Sep;64(9):685-94. doi: 10.1007/s00105-013-2623-0. Hautarzt. 2013. PMID: 24022632 German.

86

Intraoperative anaphylactic reaction IV° to gelatin.

Rauschenberg R, Beissert S, Bauer A, Spornraft-Ragaller P. Rauschenberg R, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2014 Jul;12(7):617-8. doi: 10.1111/ddg.12289. Epub 2014 May 28. J Dtsch Dermatol Ges. 2014. PMID: 24871689 No abstract available.

87

Anti-apoptotic NF-κB and "gain of function" mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF production.

Müller I, Beissert S, Kulms D. Müller I, et al. Among authors: beissert s. J Invest Dermatol. 2015 Mar;135(3):851-860. doi: 10.1038/jid.2014.481. Epub 2014 Nov 7. J Invest Dermatol. 2015. PMID: 25380350 Free PMC article.

88

[Melanoma brain metastases : Treatment options].

Rauschenberg R, Tabatabai G, Troost EG, Garzarolli M, Beissert S, Meier F. Rauschenberg R, et al. Among authors: beissert s. Hautarzt. 2016 Jul;67(7):536-43. doi: 10.1007/s00105-016-3797-z. Hautarzt. 2016. PMID: 27206449 Review. German.

89

PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.

Niessner H, Schmitz J, Tabatabai G, Schmid AM, Calaminus C, Sinnberg T, Weide B, Eigentler TK, Garbe C, Schittek B, Quintanilla-Fend L, Bender B, Mai M, Praetorius C, Beissert S, Schackert G, Muders MH, Meinhardt M, Baretton GB, Dummer R, Flaherty K, Pichler BJ, Kulms D, Westphal D, Meier F. Niessner H, et al. Among authors: beissert s. Clin Cancer Res. 2016 Dec 1;22(23):5818-5828. doi: 10.1158/1078-0432.CCR-16-0064. Epub 2016 Jun 15. Clin Cancer Res. 2016. PMID: 27307593 Free article.

90

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.

Niessner H, Sinnberg T, Kosnopfel C, Smalley KSM, Beck D, Praetorius C, Mai M, Beissert S, Kulms D, Schaller M, Garbe C, Flaherty KT, Westphal D, Wanke I, Meier F. Niessner H, et al. Among authors: beissert s. Clin Cancer Res. 2017 Oct 15;23(20):6203-6214. doi: 10.1158/1078-0432.CCR-17-0098. Epub 2017 Jul 19. Clin Cancer Res. 2017. PMID: 28724666 Free PMC article.

91

[Gastrointestinal side effects of apremilast : Characterization and management].

Pinter A, Beigel F, Körber A, Homey B, Beissert S, Gerdes S, Staubach-Renz P, Radtke MA, Mössner R. Pinter A, et al. Among authors: beissert s. Hautarzt. 2019 May;70(5):354-362. doi: 10.1007/s00105-019-4396-6. Hautarzt. 2019. PMID: 30937481 Review. German.

92

Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro.

Kroschwald LM, Tauer JT, Kroschwald SI, Suttorp M, Wiedenfeld A, Beissert S, Bauer A, Rauner M. Kroschwald LM, et al. Among authors: beissert s. Oncol Lett. 2019 Aug;18(2):2102-2108. doi: 10.3892/ol.2019.10518. Epub 2019 Jun 21. Oncol Lett. 2019. PMID: 31423283 Free PMC article.

93

Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update.

Gellrich FF, Schmitz M, Beissert S, Meier F. Gellrich FF, et al. Among authors: beissert s. J Clin Med. 2020 Jan 14;9(1):223. doi: 10.3390/jcm9010223. J Clin Med. 2020. PMID: 31947592 Free PMC article. Review.

94

Predictors of severe anaphylaxis in Hymenoptera venom allergy: The importance of absence of urticaria and angioedema.

Chapsa M, Roensch H, Langner M, Beissert S, Bauer A. Chapsa M, et al. Among authors: beissert s. Ann Allergy Asthma Immunol. 2020 Jul;125(1):72-77. doi: 10.1016/j.anai.2020.03.007. Epub 2020 Mar 18. Ann Allergy Asthma Immunol. 2020. PMID: 32199978

95

Zytokine der IL-17-Familie bei der Psoriasis.

Lauffer F, Eyerich K, Boehncke WH, Asadullah K, Beissert S, Ghoreschi K, Schön MP. Lauffer F, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Jul;18(7):675-681. doi: 10.1111/ddg.14124_g. J Dtsch Dermatol Ges. 2020. PMID: 32713148 Review. German.

96

Systemische Immunsuppression in Zeiten von COVID‐19: Müssen wir umdenken?

Grabbe S, Beissert S, Enk A. Grabbe S, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Aug;18(8):810-814. doi: 10.1111/ddg.14194_g. J Dtsch Dermatol Ges. 2020. PMID: 32881269 Free PMC article. Review. German.

97

Menter A, Arenberger P, Balser S, Beissert S, Cauthen A, Czeloth N, Soung J, Jazayeri S, Weisenseel P, Jayadeva G. Menter A, et al. Among authors: beissert s. Expert Opin Biol Ther. 2021 Jan;21(1):87-96. doi: 10.1080/14712598.2021.1851362. Epub 2020 Dec 29. Expert Opin Biol Ther. 2021. PMID: 33317345 Clinical Trial.

98

Berufsbedingte Allergie gegen Phytase: Fallserie von acht Produktionsmitarbeitern, die Futtermittelzusatzstoffen ausgesetzt waren.

Kuske M, Berndt K, Spornraft-Ragaller P, Neumeister V, Raulf M, Sander I, Koschel D, Bickhardt J, Beissert S, Bauer A. Kuske M, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Aug;18(8):859-866. doi: 10.1111/ddg.14205_g. J Dtsch Dermatol Ges. 2020. PMID: 33448641 German.

99

Systemic Therapy of Metastatic Melanoma: On the Road to Cure.

Steininger J, Gellrich FF, Schulz A, Westphal D, Beissert S, Meier F. Steininger J, et al. Among authors: beissert s. Cancers (Basel). 2021 Mar 20;13(6):1430. doi: 10.3390/cancers13061430. Cancers (Basel). 2021. PMID: 33804800 Free PMC article. Review.

100

[Metastatic squamous cell carcinoma on an ulcer in graft-versus-host disease after allogeneic stem cell transplantation].

Hobelsberger S, Meier F, Beissert S, Abraham S. Hobelsberger S, et al. Among authors: beissert s. Dermatologie (Heidelb). 2022 Sep;73(9):722-726. doi: 10.1007/s00105-021-04932-z. Epub 2022 Jan 5. Dermatologie (Heidelb). 2022. PMID: 34985572 Free PMC article. German.

101

Childhood Trauma and Psychosocial Stress Affect Treatment Outcome in Patients With Psoriasis Starting a New Treatment Episode.

Wintermann GB, Bierling AL, Peters EMJ, Abraham S, Beissert S, Weidner K. Wintermann GB, et al. Among authors: beissert s. Front Psychiatry. 2022 Apr 25;13:848708. doi: 10.3389/fpsyt.2022.848708. eCollection 2022. Front Psychiatry. 2022. PMID: 35546938 Free PMC article.

102

Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma.

Schulz A, Raetz J, Karitzky PC, Dinter L, Tietze JK, Kolbe I, Käubler T, Renner B, Beissert S, Meier F, Westphal D. Schulz A, et al. Among authors: beissert s. Cancers (Basel). 2022 Oct 8;14(19):4930. doi: 10.3390/cancers14194930. Cancers (Basel). 2022. PMID: 36230853 Free PMC article.

103

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

Grabbe S, Beissert S, Schwarz T, Granstein RD. Grabbe S, et al. Among authors: beissert s. Immunol Today. 1995 Mar;16(3):117-21. doi: 10.1016/0167-5699(95)80125-1. Immunol Today. 1995. PMID: 7718082 Review. No abstract available.

104

IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.

Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD. Beissert S, et al. J Immunol. 1995 Feb 1;154(3):1280-6. J Immunol. 1995. PMID: 7822797

105

Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells.

Grabbe S, Bruvers S, Beissert S, Granstein RD. Grabbe S, et al. Among authors: beissert s. J Leukoc Biol. 1994 Jun;55(6):695-701. doi: 10.1002/jlb.55.6.695. J Leukoc Biol. 1994. PMID: 8195694

106

[Pemphigus herpetiformis].

Beissert S, Metze D, Luger TA, Schwarz T. Beissert S, et al. Hautarzt. 1993 Sep;44(9):594-7. Hautarzt. 1993. PMID: 8407328 German.

107

Bullous pemphigoid treated with mycophenolate mofetil.

Böhm M, Beissert S, Schwarz T, Metze D, Luger T. Böhm M, et al. Among authors: beissert s. Lancet. 1997 Feb 22;349(9051):541. doi: 10.1016/S0140-6736(97)80092-X. Lancet. 1997. PMID: 9048797 No abstract available.

108

Impaired cutaneous immune responses in Thy-1-deficient mice.

Beissert S, He HT, Hueber AO, Lellouch AC, Metze D, Mehling A, Luger TA, Schwarz T, Grabbe S. Beissert S, et al. J Immunol. 1998 Nov 15;161(10):5296-302. J Immunol. 1998. PMID: 9820502

109

[Embolia cutis medicamentosa (Nicolau syndrome) after intra-articular injection].

Beissert S, Presser D, Rütter A, Metze D, Luger TA, Schwarz T. Beissert S, et al. Hautarzt. 1999 Mar;50(3):214-6. doi: 10.1007/s001050050892. Hautarzt. 1999. PMID: 10231693 German.

110

Lipodystrophia centrifugalis abdominalis infantilis in a 4-year-old Caucasian girl: association with partial IgA deficiency and autoantibodies.

Müller S, Beissert S, Metze D, Luger TA, Bonsmann G. Müller S, et al. Among authors: beissert s. Br J Dermatol. 1999 Jun;140(6):1161-4. doi: 10.1046/j.1365-2133.1999.02882.x. Br J Dermatol. 1999. PMID: 10354090 Review.

111

Mechanisms involved in ultraviolet light-induced immunosuppression.

Beissert S, Schwarz T. Beissert S, et al. J Investig Dermatol Symp Proc. 1999 Sep;4(1):61-4. doi: 10.1038/sj.jidsp.5640183. J Investig Dermatol Symp Proc. 1999. PMID: 10537010 Free article. Review.

112

Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation.

Beissert S, Bluestone JA, Mindt I, Voskort M, Metze D, Mehling A, Luger TA, Schwarz T, Grabbe S. Beissert S, et al. J Immunol. 1999 Dec 15;163(12):6725-31. J Immunol. 1999. PMID: 10586070

113

Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.

Schwarz A, Beissert S, Grosse-Heitmeyer K, Gunzer M, Bluestone JA, Grabbe S, Schwarz T. Schwarz A, et al. Among authors: beissert s. J Immunol. 2000 Aug 15;165(4):1824-31. doi: 10.4049/jimmunol.165.4.1824. J Immunol. 2000. PMID: 10925260

114

Mycophenolate mofetil impairs the maturation and function of murine dendritic cells.

Mehling A, Grabbe S, Voskort M, Schwarz T, Luger TA, Beissert S. Mehling A, et al. Among authors: beissert s. J Immunol. 2000 Sep 1;165(5):2374-81. doi: 10.4049/jimmunol.165.5.2374. J Immunol. 2000. PMID: 10946260

115

Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity.

Mehling A, Loser K, Varga G, Metze D, Luger TA, Schwarz T, Grabbe S, Beissert S. Mehling A, et al. Among authors: beissert s. J Exp Med. 2001 Sep 3;194(5):615-28. doi: 10.1084/jem.194.5.615. J Exp Med. 2001. PMID: 11535630 Free PMC article.

116

IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis.

Beissert S, Rühlemann D, Mohammad T, Grabbe S, El-Ghorr A, Norval M, Morrison H, Granstein RD, Schwarz T. Beissert S, et al. J Immunol. 2001 Dec 1;167(11):6232-8. doi: 10.4049/jimmunol.167.11.6232. J Immunol. 2001. PMID: 11714785

117

Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells.

Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, Bloch W, Peters T, Schwarz T, Sunderkötter C, Scharffetter-Kochanek K. Grabbe S, et al. Among authors: beissert s. J Clin Invest. 2002 Jan;109(2):183-92. doi: 10.1172/JCI11703. J Clin Invest. 2002. PMID: 11805130 Free PMC article.

118

Role of immunomodulation in diseases responsive to phototherapy.

Beissert S, Schwarz T. Beissert S, et al. Methods. 2002 Sep;28(1):138-44. doi: 10.1016/s1046-2023(02)00217-7. Methods. 2002. PMID: 12231198 Review.

119

Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity.

Schwarz A, Maeda A, Wild MK, Kernebeck K, Gross N, Aragane Y, Beissert S, Vestweber D, Schwarz T. Schwarz A, et al. Among authors: beissert s. J Immunol. 2004 Jan 15;172(2):1036-43. doi: 10.4049/jimmunol.172.2.1036. J Immunol. 2004. PMID: 14707077

120

Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15.

Loser K, Mehling A, Apelt J, Ständer S, Andres PG, Reinecker HC, Eing BR, Skryabin BV, Varga G, Schwarz T, Beissert S. Loser K, et al. Among authors: beissert s. Eur J Immunol. 2004 Jul;34(7):2022-31. doi: 10.1002/eji.200324785. Eur J Immunol. 2004. PMID: 15214050 Free article.

121

Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair.

Schwarz A, Maeda A, Kernebeck K, van Steeg H, Beissert S, Schwarz T. Schwarz A, et al. Among authors: beissert s. J Exp Med. 2005 Jan 17;201(2):173-9. doi: 10.1084/jem.20041212. J Exp Med. 2005. PMID: 15657287 Free PMC article.

122

An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.

Loser K, Scherer A, Krummen MB, Varga G, Higuchi T, Schwarz T, Sharpe AH, Grabbe S, Bluestone JA, Beissert S. Loser K, et al. Among authors: beissert s. J Immunol. 2005 May 1;174(9):5298-305. doi: 10.4049/jimmunol.174.9.5298. J Immunol. 2005. PMID: 15843526

123

[Daily relations with UV and prevention of photoaging of skin -- introduction to the topic].

Luger TA, Beissert S. Luger TA, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2005 Sep;3 Suppl 2:S1-2. doi: 10.1111/j.1610-0387.2005.04399.x. J Dtsch Dermatol Ges. 2005. PMID: 16117737 German. No abstract available.

124

[Sunprotection: possibilities and limitations].

Elsner P, Beissert S, Luger TA. Elsner P, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2005 Sep;3 Suppl 2:S40-4. doi: 10.1111/j.1610-0387.2005.04398.x. J Dtsch Dermatol Ges. 2005. PMID: 16117744 German.

125

Enhanced photocarcinogenesis in interleukin-12-deficient mice.

Maeda A, Schneider SW, Kojima M, Beissert S, Schwarz T, Schwarz A. Maeda A, et al. Among authors: beissert s. Cancer Res. 2006 Mar 15;66(6):2962-9. doi: 10.1158/0008-5472.CAN-05-3614. Cancer Res. 2006. PMID: 16540644

126

Migration of immature mouse DC across resting endothelium is mediated by ICAM-2 but independent of beta2-integrins and murine DC-SIGN homologues.

Wethmar K, Helmus Y, Lühn K, Jones C, Laskowska A, Varga G, Grabbe S, Lyck R, Engelhardt B, Bixel MG, Butz S, Loser K, Beissert S, Ipe U, Vestweber D, Wild MK. Wethmar K, et al. Among authors: beissert s. Eur J Immunol. 2006 Oct;36(10):2781-94. doi: 10.1002/eji.200526311. Eur J Immunol. 2006. PMID: 16981228 Free article.

127

Structure and duration of contact between dendritic cells and T cells are controlled by T cell activation state.

Rothoeft T, Balkow S, Krummen M, Beissert S, Varga G, Loser K, Oberbanscheidt P, van den Boom F, Grabbe S. Rothoeft T, et al. Among authors: beissert s. Eur J Immunol. 2006 Dec;36(12):3105-17. doi: 10.1002/eji.200636145. Eur J Immunol. 2006. PMID: 17111349 Free article.

128

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.

Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, Schwarz T, Penninger JM, Beissert S. Loser K, et al. Among authors: beissert s. Nat Med. 2006 Dec;12(12):1372-9. doi: 10.1038/nm1518. Epub 2006 Dec 3. Nat Med. 2006. PMID: 17143276

129

Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.

Loeser S, Loser K, Bijker MS, Rangachari M, van der Burg SH, Wada T, Beissert S, Melief CJ, Penninger JM. Loeser S, et al. Among authors: beissert s. J Exp Med. 2007 Apr 16;204(4):879-91. doi: 10.1084/jem.20061699. Epub 2007 Apr 2. J Exp Med. 2007. PMID: 17403934 Free PMC article.

130

Introduction of diagnosis-related groups in Germany: evaluation of impact on in-patient care in a dermatological setting.

Hensen P, Beissert S, Bruckner-Tuderman L, Luger TA, Roeder N, Müller ML. Hensen P, et al. Among authors: beissert s. Eur J Public Health. 2008 Feb;18(1):85-91. doi: 10.1093/eurpub/ckm059. Epub 2007 Jun 14. Eur J Public Health. 2008. PMID: 17569699

131

IL-10 controls ultraviolet-induced carcinogenesis in mice.

Loser K, Apelt J, Voskort M, Mohaupt M, Balkow S, Schwarz T, Grabbe S, Beissert S. Loser K, et al. Among authors: beissert s. J Immunol. 2007 Jul 1;179(1):365-71. doi: 10.4049/jimmunol.179.1.365. J Immunol. 2007. PMID: 17579057

132

A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA. Beissert S, et al. Arch Dermatol. 2007 Dec;143(12):1536-42. doi: 10.1001/archderm.143.12.1536. Arch Dermatol. 2007. PMID: 18087004 Clinical Trial.

133

Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells.

Maeda A, Beissert S, Schwarz T, Schwarz A. Maeda A, et al. Among authors: beissert s. J Immunol. 2008 Mar 1;180(5):3065-71. doi: 10.4049/jimmunol.180.5.3065. J Immunol. 2008. PMID: 18292529

134

Antihistamine combination treatment for solar urticaria.

Grundmann SA, Ständer S, Luger TA, Beissert S. Grundmann SA, et al. Among authors: beissert s. Br J Dermatol. 2008 Jun;158(6):1384-6. doi: 10.1111/j.1365-2133.2008.08543.x. Epub 2008 Apr 2. Br J Dermatol. 2008. PMID: 18384474 No abstract available.

135

Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells.

Loser K, Sturm A, Voskort M, Kupas V, Balkow S, Auriemma M, Sternemann C, Dignass AU, Luger TA, Beissert S. Loser K, et al. Among authors: beissert s. J Immunol. 2009 May 1;182(9):5419-29. doi: 10.4049/jimmunol.0802308. J Immunol. 2009. PMID: 19380789

136

Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain.

Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E, Loser K, Beissert S, Georges-Labouesse E, Sorokin LM. Wu C, et al. Among authors: beissert s. Nat Med. 2009 May;15(5):519-27. doi: 10.1038/nm.1957. Epub 2009 Apr 26. Nat Med. 2009. PMID: 19396173

137

Ultraviolet-induced immunosuppression: implications for photocarcinogenesis.

Beissert S, Schwarz T. Beissert S, et al. Cancer Treat Res. 2009;146:109-21. doi: 10.1007/978-0-387-78574-5_10. Cancer Treat Res. 2009. PMID: 19415197 Review. No abstract available.

138

A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.

Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA. Beissert S, et al. Dermatology. 2009;219(2):126-32. doi: 10.1159/000226134. Epub 2009 Jun 23. Dermatology. 2009. PMID: 19546522 Clinical Trial.

139

The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.

Loser K, Brzoska T, Oji V, Auriemma M, Voskort M, Kupas V, Klenner L, Mensing C, Hauschild A, Beissert S, Luger TA. Loser K, et al. Among authors: beissert s. PLoS One. 2010 Feb 1;5(2):e8958. doi: 10.1371/journal.pone.0008958. PLoS One. 2010. PMID: 20126537 Free PMC article.

140

Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus.

Kuhn A, Meuth AM, Bein D, Amler S, Beissert S, Böhm M, Brehler R, Ehrchen J, Grundmann S, Haust M, Ruland V, Schiller M, Schulz P, Ständer S, Sauerland C, Köpcke W, Luger TA, Bonsmann G. Kuhn A, et al. Among authors: beissert s. Br J Dermatol. 2010 Jul;163(1):83-92. doi: 10.1111/j.1365-2133.2010.09799.x. Epub 2010 Apr 12. Br J Dermatol. 2010. PMID: 20394621

141

The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells.

Loser K, Vogl T, Voskort M, Lueken A, Kupas V, Nacken W, Klenner L, Kuhn A, Foell D, Sorokin L, Luger TA, Roth J, Beissert S. Loser K, et al. Among authors: beissert s. Nat Med. 2010 Jun;16(6):713-7. doi: 10.1038/nm.2150. Epub 2010 May 9. Nat Med. 2010. PMID: 20473308

142

Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin.

Meyer V, Goerge T, Luger TA, Beissert S. Meyer V, et al. Among authors: beissert s. J Clin Aesthet Dermatol. 2011 Apr;4(4):45-6. J Clin Aesthet Dermatol. 2011. PMID: 21532878 Free PMC article.

143

Experimentally confirmed induction of Sweet's syndrome by phototesting.

Meyer V, Schneider SW, Bonsmann G, Beissert S. Meyer V, et al. Among authors: beissert s. Acta Derm Venereol. 2011 Oct;91(6):720-1. doi: 10.2340/00015555-1139. Acta Derm Venereol. 2011. PMID: 21681361 Free article. No abstract available.

144

Tissue microarray analysis of RANKL in cutaneous lupus erythematosus and psoriasis.

Toberer F, Sykora J, Göttel D, Ruland V, Hartschuh W, Enk A, Luger TA, Beissert S, Loser K, Joos S, Krammer PH, Kuhn A. Toberer F, et al. Among authors: beissert s. Exp Dermatol. 2011 Jul;20(7):600-2. doi: 10.1111/j.1600-0625.2011.01303.x. Exp Dermatol. 2011. PMID: 21692859

145

Milestones in photoimmunology.

Schwarz T, Beissert S. Schwarz T, et al. Among authors: beissert s. J Invest Dermatol. 2013 Jul 1;133(E1):E7-E10. doi: 10.1038/skinbio.2013.177. J Invest Dermatol. 2013. PMID: 23820723 Free article. Review. No abstract available.

146

In vitro induced CD8+ regulatory T cells inhibit skin inflammation.

Fleissner D, Loser K, Hansen W, Dissemond J, Körber A, Beissert S, Buer J, Westendorf AM. Fleissner D, et al. Among authors: beissert s. Eur J Microbiol Immunol (Bp). 2011 Sep;1(3):208-14. doi: 10.1556/EuJMI.1.2011.3.4. Epub 2011 Sep 9. Eur J Microbiol Immunol (Bp). 2011. PMID: 24516726 Free PMC article.

147

Verantwortlicher Umgang mit Antibiotika: Notwendigkeit der Antibiotikareduktion in der Aknetherapie.

Gollnick HP, Buer J, Beissert S, Sunderkätter C. Gollnick HP, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2016 Dec;14(12):1319-1327. doi: 10.1111/ddg.13048. J Dtsch Dermatol Ges. 2016. PMID: 27992149

148

Charakteristika und Koinfektionen mit Syphilis bei neu mit HIV diagnostizierten Patienten aus dem Universitätsklinikum Dresden von 1987-2012.

Spornraft-Ragaller P, Schmitt J, Stephan V, Boashie U, Beissert S. Spornraft-Ragaller P, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2014 Aug;12(8):707-716. doi: 10.1111/ddg.12382_suppl. J Dtsch Dermatol Ges. 2014. PMID: 28349637 German. No abstract available.

149

Nicht IgE-vermittelte Hypersensitivität auf Macrogol 6000.

Berndt K, Kuske M, Beissert S, Spornraft-Ragaller P, Bauer A. Berndt K, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2018 Apr;16(4):478-480. doi: 10.1111/ddg.13479_g. J Dtsch Dermatol Ges. 2018. PMID: 29645387 No abstract available.

150

[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].

Haufe E, Abraham S, Heratizadeh A, Harder I, Zink A, Weisshaar E, Kleinheinz A, von Kiedrowski R, Worm M, Bell M, Wollenberg A, Neubert K, Staubach-Renz P, Hilgers M, Bieber T, Fell I, Homey B, Effendy I, Mempel M, Schäkel K, Beissert S, Weidinger S, Werfel T, Schmitt J. Haufe E, et al. Among authors: beissert s. Hautarzt. 2018 Oct;69(10):815-824. doi: 10.1007/s00105-018-4261-z. Hautarzt. 2018. PMID: 30191254 German.

151

Epidermolytische Ichthyose mit Nachweis einer De-novo-Missense-Mutation c.1307T>C; p.Leu436Pro in KRT10.

Kuske M, Berndt K, Meinel G, Abraham S, Oji V, Reicherter K, Hörtnagel K, Beissert S, Bauer A. Kuske M, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2019 Jan;17(1):82-84. doi: 10.1111/ddg.13720_g. J Dtsch Dermatol Ges. 2019. PMID: 30615288 No abstract available.

152

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.

Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L, Girolomoni G, de Bruin-Weller M, Wollenberg A, Kataoka Y, Remitz A, Beissert S, Mastey V, Ardeleanu M, Chen Z, Gadkari A, Chao J. Cork MJ, et al. Among authors: beissert s. J Dermatolog Treat. 2020 Sep;31(6):606-614. doi: 10.1080/09546634.2019.1612836. Epub 2019 Jun 9. J Dermatolog Treat. 2020. PMID: 31179791 Free article. Clinical Trial.

153

An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.

Kolb-Mäurer A, Sunderkötter C, Kukowski B, Meuth SG; members of an expert meeting. Kolb-Mäurer A, et al. BMC Neurol. 2019 Jun 15;19(1):130. doi: 10.1186/s12883-019-1354-y. BMC Neurol. 2019. PMID: 31202258 Free PMC article.

154

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.

Worm M, Simpson EL, Thaçi D, Bissonnette R, Lacour JP, Beissert S, Kawashima M, Ferrándiz C, Smith CH, Beck LA, Chan KC, Chen Z, Akinlade B, Hultsch T, Staudinger H, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Ardeleanu M. Worm M, et al. Among authors: beissert s. JAMA Dermatol. 2020 Feb 1;156(2):131-143. doi: 10.1001/jamadermatol.2019.3617. JAMA Dermatol. 2020. PMID: 31876900 Free PMC article. Clinical Trial.

155

COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen.

Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. Buhl T, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2020 Aug;18(8):815-825. doi: 10.1111/ddg.14195_g. J Dtsch Dermatol Ges. 2020. PMID: 32881343 Free PMC article. Review. German.

156

Trimethylolpropane poly(oxypropylene)triamine: A new contact allergen in water-based metalworking fluids.

Hasler H, Heyne S, Geier J, Beissert S, Bauer A. Hasler H, et al. Among authors: beissert s. Contact Dermatitis. 2023 Jul;89(1):74-76. doi: 10.1111/cod.14326. Epub 2023 May 8. Contact Dermatitis. 2023. PMID: 37156736 No abstract available.

157

Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice.

Beissert S, Hosoi J, Kühn R, Rajewsky K, Müller W, Granstein RD. Beissert S, et al. J Invest Dermatol. 1996 Oct;107(4):553-7. doi: 10.1111/1523-1747.ep12582809. J Invest Dermatol. 1996. PMID: 8823360 Free article.

158

Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta.

Beissert S, Hosoi J, Stratigos A, Brissette J, Grabbe S, Schwarz T, Granstein RD. Beissert S, et al. J Invest Dermatol. 1998 Oct;111(4):609-15. doi: 10.1046/j.1523-1747.1998.00291.x. J Invest Dermatol. 1998. PMID: 9764841 Free article.

159

Tumor antigen presentation by dermal antigen-presenting cells.

Campton K, Ding W, Yan Z, Ozawa H, Seiffert K, Miranda E, Lonati A, Beissert S, Granstein RD. Campton K, et al. Among authors: beissert s. J Invest Dermatol. 2000 Jul;115(1):57-61. doi: 10.1046/j.1523-1747.2000.00014.x. J Invest Dermatol. 2000. PMID: 10886508 Free article.

160

Neuropilin-1: a surface marker of regulatory T cells.

Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. Bruder D, et al. Among authors: beissert s. Eur J Immunol. 2004 Mar;34(3):623-630. doi: 10.1002/eji.200324799. Eur J Immunol. 2004. PMID: 14991591 Free article.

161

In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity.

Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S. Loser K, et al. Among authors: beissert s. Gene Ther. 2005 Sep;12(17):1294-304. doi: 10.1038/sj.gt.3302567. Gene Ther. 2005. PMID: 15973443

162

IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen.

Riemann H, Loser K, Beissert S, Fujita M, Schwarz A, Schwarz T, Grabbe S. Riemann H, et al. Among authors: beissert s. J Immunol. 2005 Nov 1;175(9):5866-74. doi: 10.4049/jimmunol.175.9.5866. J Immunol. 2005. PMID: 16237079

163

Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells.

Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M. Veldman C, et al. Among authors: beissert s. J Immunol. 2006 Mar 1;176(5):3215-22. doi: 10.4049/jimmunol.176.5.3215. J Immunol. 2006. PMID: 16493082

164

CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.

Kuhn A, Beissert S, Krammer PH. Kuhn A, et al. Among authors: beissert s. Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Arch Dermatol Res. 2009. PMID: 18985367 Review.

165

Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.

Balkow S, Loser K, Krummen M, Higuchi T, Rothoeft T, Apelt J, Tuettenberg A, Weishaupt C, Beissert S, Grabbe S. Balkow S, et al. Among authors: beissert s. Exp Dermatol. 2009 Jan;18(1):78-87. doi: 10.1111/j.1600-0625.2008.00800.x. Epub 2008 Oct 22. Exp Dermatol. 2009. PMID: 19054060

166

RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells.

Kupas V, Weishaupt C, Siepmann D, Kaserer ML, Eickelmann M, Metze D, Luger TA, Beissert S, Loser K. Kupas V, et al. Among authors: beissert s. J Invest Dermatol. 2011 Apr;131(4):944-55. doi: 10.1038/jid.2010.377. Epub 2011 Jan 27. J Invest Dermatol. 2011. PMID: 21270824 Free article.

167

Modern aspects of phototherapy for atopic dermatitis.

Grundmann SA, Beissert S. Grundmann SA, et al. Among authors: beissert s. J Allergy (Cairo). 2012;2012:121797. doi: 10.1155/2012/121797. Epub 2011 Dec 15. J Allergy (Cairo). 2012. PMID: 22220185 Free PMC article.

168

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.

Werth VP, Joly P, Mimouni D, Maverakis E, Caux F, Lehane P, Gearhart L, Kapre A, Pordeli P, Chen DM; PEMPHIX Study Group. Werth VP, et al. N Engl J Med. 2021 Jun 17;384(24):2295-2305. doi: 10.1056/NEJMoa2028564. Epub 2021 May 19. N Engl J Med. 2021. PMID: 34097368 Clinical Trial.

169

Intraoperative anaphylaxis to atracurium.

Bruhn I, Bauer A, Beissert S, Neumeister V, Spornraft-Ragaller P. Bruhn I, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2021 Dec;19(12):1784-1785. doi: 10.1111/ddg.14632. Epub 2021 Nov 25. J Dtsch Dermatol Ges. 2021. PMID: 34821049 No abstract available.

170

Intraoperative Anaphylaxie auf Atracurium.

Bruhn I, Bauer A, Beissert S, Neumeister V, Spornraft-Ragaller P. Bruhn I, et al. Among authors: beissert s. J Dtsch Dermatol Ges. 2021 Dec;19(12):1784-1786. doi: 10.1111/ddg.14632_g. J Dtsch Dermatol Ges. 2021. PMID: 34894190 German. No abstract available.

171

Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse.

Kondo S, Beissert S, Wang B, Fujisawa H, Kooshesh F, Stratigos A, Granstein RD, Mak TW, Sauder DN. Kondo S, et al. Among authors: beissert s. J Invest Dermatol. 1996 May;106(5):993-1000. doi: 10.1111/1523-1747.ep12338505. J Invest Dermatol. 1996. PMID: 8618064 Free article.

172

Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice.

Starcher B, O'Neal P, Granstein RD, Beissert S. Starcher B, et al. Among authors: beissert s. J Invest Dermatol. 1996 Aug;107(2):159-63. doi: 10.1111/1523-1747.ep12329559. J Invest Dermatol. 1996. PMID: 8757756 Free article.

173

Photosensitivity in lupus erythematosus.

Kuhn A, Beissert S. Kuhn A, et al. Among authors: beissert s. Autoimmunity. 2005 Nov;38(7):519-29. doi: 10.1080/08916930500285626. Autoimmunity. 2005. PMID: 16373257 Review.

174

G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo.

Hansen W, Loser K, Westendorf AM, Bruder D, Pfoertner S, Siewert C, Huehn J, Beissert S, Buer J. Hansen W, et al. Among authors: beissert s. J Immunol. 2006 Jul 1;177(1):209-15. doi: 10.4049/jimmunol.177.1.209. J Immunol. 2006. PMID: 16785516

175

Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation.

Varga G, Balkow S, Wild MK, Stadtbaeumer A, Krummen M, Rothoeft T, Higuchi T, Beissert S, Wethmar K, Scharffetter-Kochanek K, Vestweber D, Grabbe S. Varga G, et al. Among authors: beissert s. Blood. 2007 Jan 15;109(2):661-9. doi: 10.1182/blood-2005-12-023044. Epub 2006 Sep 26. Blood. 2007. PMID: 17003381 Free article.

176

Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse.

Reichardt P, Dornbach B, Rong S, Beissert S, Gueler F, Loser K, Gunzer M. Reichardt P, et al. Among authors: beissert s. Blood. 2007 Sep 1;110(5):1519-29. doi: 10.1182/blood-2006-10-053793. Epub 2007 Mar 28. Blood. 2007. PMID: 17392507 Free article.

177

Molecular and cellular mechanisms of photocarcinogenesis.

Beissert S, Loser K. Beissert S, et al. Photochem Photobiol. 2008 Jan-Feb;84(1):29-34. doi: 10.1111/j.1751-1097.2007.00231.x. Photochem Photobiol. 2008. PMID: 18173698 Review.

178

Regulation of cellular immunity by Photo(chemo)therapy.

Grundmann SA, Beissert S. Grundmann SA, et al. Among authors: beissert s. Front Biosci (Landmark Ed). 2009 Jan 1;14(11):4326-36. doi: 10.2741/3530. Front Biosci (Landmark Ed). 2009. PMID: 19273352 Free article. Review.

179

Regulation of cutaneous immunity by the environment: an important role for UV irradiation and vitamin D.

Loser K, Beissert S. Loser K, et al. Among authors: beissert s. Int Immunopharmacol. 2009 May;9(5):587-9. doi: 10.1016/j.intimp.2009.01.024. Epub 2009 Feb 1. Int Immunopharmacol. 2009. PMID: 19539561 Review.

180

Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.

Müller I, Strozyk E, Schindler S, Beissert S, Oo HZ, Sauter T, Lucarelli P, Raeth S, Hausser A, Al Nakouzi N, Fazli L, Gleave ME, Liu H, Simon HU, Walczak H, Green DR, Bartek J, Daugaard M, Kulms D. Müller I, et al. Among authors: beissert s. Mol Cell. 2020 Mar 5;77(5):970-984.e7. doi: 10.1016/j.molcel.2019.12.023. Epub 2020 Jan 22. Mol Cell. 2020. PMID: 31982308 Free PMC article.

181

Impact of facial and truncal acne on quality of life: A multi-country population-based survey.

Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, Lain E, Layton A, Rocha M, Weiss J, Dréno B. Tan J, et al. Among authors: beissert s. JAAD Int. 2021 Apr 27;3:102-110. doi: 10.1016/j.jdin.2021.03.002. eCollection 2021 Jun. JAAD Int. 2021. PMID: 34409378 Free PMC article.

182

Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel.

Tan J, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, Dréno B, Gold LS, Harper J, Lynde C, Thiboutot D, Weiss J, Layton AM. Tan J, et al. Among authors: beissert s. JAAD Int. 2021 Aug 17;5:33-40. doi: 10.1016/j.jdin.2021.06.007. eCollection 2021 Dec. JAAD Int. 2021. PMID: 34816132 Free PMC article.

183

Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panel.

Layton A, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, Dréno B, Gold LS, Harper J, Lynde C, Thiboutot D, Weiss J, Tan J. Layton A, et al. Among authors: beissert s. JAAD Int. 2021 Aug 17;5:41-48. doi: 10.1016/j.jdin.2021.06.006. eCollection 2021 Dec. JAAD Int. 2021. PMID: 34816133 Free PMC article.

184

The Personalised Acne Care Pathway-Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts.

Tan J, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, Dréno B, Gold LS, Harper J, Lynde C, Thiboutot D, Weiss J, Layton AM. Tan J, et al. Among authors: beissert s. JAAD Int. 2021 Oct 18;5:101-111. doi: 10.1016/j.jdin.2021.09.006. eCollection 2021 Dec. JAAD Int. 2021. PMID: 34816135 Free PMC article.

185

Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study.

Tan J, Beissert S, Cook-Bolden F, Chavda R, Harper J, Hebert A, Lain E, Layton A, Rocha M, Weiss J, Dréno B. Tan J, et al. Among authors: beissert s. JAAD Int. 2021 Dec 23;6:43-50. doi: 10.1016/j.jdin.2021.11.006. eCollection 2022 Mar. JAAD Int. 2021. PMID: 35005652 Free PMC article.

186

Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma.

Del Mistro G, Riemann S, Schindler S, Beissert S, Kontermann RE, Ginolhac A, Halder R, Presta L, Sinkkonen L, Sauter T, Kulms D. Del Mistro G, et al. Among authors: beissert s. Cell Death Dis. 2022 Jan 12;13(1):54. doi: 10.1038/s41419-022-04502-8. Cell Death Dis. 2022. PMID: 35022419 Free PMC article.

187

Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.

Beissert S, Ullrich SE, Hosoi J, Granstein RD. Beissert S, et al. J Leukoc Biol. 1995 Aug;58(2):234-40. doi: 10.1002/jlb.58.2.234. J Leukoc Biol. 1995. PMID: 7643016

188

Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide.

Torii H, Hosoi J, Beissert S, Xu S, Fox FE, Asahina A, Takashima A, Rook AH, Granstein RD. Torii H, et al. Among authors: beissert s. J Leukoc Biol. 1997 Feb;61(2):216-23. doi: 10.1002/jlb.61.2.216. J Leukoc Biol. 1997. PMID: 9021928

189

Regulation of tumor antigen presentation by urocanic acid.

Beissert S, Mohammad T, Torri H, Lonati A, Yan Z, Morrison H, Granstein RD. Beissert S, et al. J Immunol. 1997 Jul 1;159(1):92-6. J Immunol. 1997. PMID: 9200443

190

Involvement of interleukin-3 in delayed-type hypersensitivity.

Mach N, Lantz CS, Galli SJ, Reznikoff G, Mihm M, Small C, Granstein R, Beissert S, Sadelain M, Mulligan RC, Dranoff G. Mach N, et al. Among authors: beissert s. Blood. 1998 Feb 1;91(3):778-83. Blood. 1998. PMID: 9446636 Free article.

191

Use of mutant mice in photoimmunological and photocarcinogenic investigations.

Beissert S. Beissert S. Methods. 2002 Sep;28(1):130-7. doi: 10.1016/s1046-2023(02)00216-5. Methods. 2002. PMID: 12231197 Review.

192

Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis.

Ding W, Beissert S, Deng L, Miranda E, Cassetty C, Seiffert K, Campton KL, Yan Z, Murphy GF, Bluestone JA, Granstein RD. Ding W, et al. Among authors: beissert s. J Clin Invest. 2003 Jun;111(12):1923-31. doi: 10.1172/JCI15722. J Clin Invest. 2003. PMID: 12813028 Free PMC article.

193

Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing.

Vörsmann H, Groeber F, Walles H, Busch S, Beissert S, Walczak H, Kulms D. Vörsmann H, et al. Among authors: beissert s. Cell Death Dis. 2013 Jul 11;4(7):e719. doi: 10.1038/cddis.2013.249. Cell Death Dis. 2013. PMID: 23846221 Free PMC article.

194

Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.

Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD. Asahina A, et al. Among authors: beissert s. J Immunol. 1995 Apr 1;154(7):3056-61. J Immunol. 1995. PMID: 7897198

195

Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma.

Del Mistro G, Lucarelli P, Müller I, De Landtsheer S, Zinoveva A, Hutt M, Siegemund M, Kontermann RE, Beissert S, Sauter T, Kulms D. Del Mistro G, et al. Among authors: beissert s. NPJ Syst Biol Appl. 2018 Nov 5;4:39. doi: 10.1038/s41540-018-0075-y. eCollection 2018. NPJ Syst Biol Appl. 2018. PMID: 30416750 Free PMC article.

196

Heterogeneity of tumour necrosis factor production in renal cell carcinoma.

Waase I, Bergholz M, Iglauer A, Beissert S, Blech M, Schauer A, Krönke M. Waase I, et al. Among authors: beissert s. Eur J Cancer. 1992;28A(10):1660-4. doi: 10.1016/0959-8049(92)90063-8. Eur J Cancer. 1992. PMID: 1389482

197

Granulocyte macrophage colony-stimulating factor deficiency affects vascular elastin production and integrity of elastic lamellae.

Weissen-Plenz G, Eschert H, Volker W, Sindermann JR, Beissert S, Robenek H, Scheld HH, Breithardt G. Weissen-Plenz G, et al. Among authors: beissert s. J Vasc Res. 2008;45(2):103-10. doi: 10.1159/000109819. Epub 2007 Oct 12. J Vasc Res. 2008. PMID: 17934321

198

Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF) -deficient mice.

Plenz G, Eschert H, Beissert S, Arps V, Sindermann JR, Robenek H, Völker W. Plenz G, et al. Among authors: beissert s. FASEB J. 2003 Aug;17(11):1451-7. doi: 10.1096/fj.02-1035com. FASEB J. 2003. PMID: 12890699

199

Efficacy of two compression systems in the management of VLUs: results of a European RCT.

Lazareth I, Moffatt C, Dissemond J, Lesne Padieu AS, Truchetet F, Beissert S, Wicks G, Tilbe H, Sauvadet A, Bohbot S, Meaume S. Lazareth I, et al. Among authors: beissert s. J Wound Care. 2012 Nov;21(11):553-4, 556, 558 passim. doi: 10.12968/jowc.2012.21.11.553. J Wound Care. 2012. PMID: 23413494 Clinical Trial.

200

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Beissert S, Bergholz M, Waase I, Lepsien G, Schauer A, Pfizenmaier K, Krönke M. Beissert S, et al. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5064-8. doi: 10.1073/pnas.86.13.5064. Proc Natl Acad Sci U S A. 1989. PMID: 2662193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page